Progyny
New York
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians. Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so. Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $1M – $10M
- Total funding: $315.5M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2025)
- Ticker: nasdaq:PGNY
- Website: progyny.com
- Phone: (212)888-3124
Industries & Categories
Fertility, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/progyny-58458 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.